Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TCT 2021 | HSCT & CAR-T therapy during COVID-19: Chinese experience

He Huang • 2 Feb 2021
TCT 2021
General

He Huang, MD, PhD, Zhejiang University, Hangzhou, China, outlines the impact of the COVID-19 pandemic on haploidentical stem cell transplantation (HSCT) and CAR T-cell therapy in China. Prof. Huang outlines infrastructure changes in response to the pandemic and provides an overview of the management strategies implemented for patients with hematological malignancies during the COVID-19 pandemic as well as changes in care following HSCT. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

More from He Huang

An update on the experience with CAR T-cell therapy in China
3:09
An update on the experience with CAR T-cell therapy in China
He Huang • 16 Feb 2024
Novel CAR T-cell therapies for hematological malignancies: exploring new targets
4:17
Novel CAR T-cell therapies for hematological malignancies: exploring new targets
He Huang • 16 Feb 2024
Managing CRS after anti-BCMA CAR-T for myeloma
1:19
Managing CRS after anti-BCMA CAR-T for myeloma
He Huang • 17 May 2019
CAR-T cells for myeloma: experience from China
2:37
CAR-T cells for myeloma: experience from China
He Huang • 16 May 2019

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals